Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4252866 | Cirugía Española | 2013 | 8 Pages |
Abstract
Treatment of lung carcinoma is multidisciplinary. There are different therapeutic strategies available, although surgery shows the best results in those patients with lung carcinoma in early stages. Other options such as stereotactic radiation therapy are relegated to patients with small tumors and poor cardiopulmonary reserve or to those who reject surgery. Adjuvant chemotherapy is not justified in patients with stage i of the disease and so double adjuvant chemotherapy should be considered. This adjuvant chemotherapy should be based on cisplatin after surgery in those patients with stages ii and IIIA.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
José Carlos Meneses, Régulo J. Ávila MartÃnez, Santiago Ponce, Mauricio Zuluaga, Adela Bartolomé, Pablo Gámez,